Ph. I Dasatinib/Protracted Temozolomide in Recurrent Malignant Glioma
Stopped Study drug supplier withdrew support for the study. Study was withdrawn from the Duke IRB.
Conditions
- Glioblastoma Multiforme
- Gliosarcoma
- Anaplastic Astrocytoma
- Anaplastic Oligodendroglioma
- Glioma
Interventions
- DRUG: enzyme-inducing anti-epileptic drugs
- DRUG: enzyme-inducing anti-epileptic drugs
Sponsor
Annick Desjardins
Collaborators